Mican, your statement is good for the lawyers that it could be "malpractice to make a patient go through a series of relapses before pona". knowing that there is a 100% chance of mutation in other TKIs versus the AEs in pona, the doctors should give the patients the freedom of choice in treatment. If they don't give patients the choice, they could be liable for malpractice. Others, can you weigh in on this?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.